synsyscp

  • +91-9158469227
  • info@synsyscp.com
Linkedin
Menu
Enquire Now

Precision in Synthesis, Excellence in Delivery

Trusted solutions for enhancing reliability, performance, and safety across industries.

Explore Products

About Synsys

At Synsys Chemicals & Pharmaceutical LLP, we are a dynamic start-up organization dedicated to providing specialized services to the chemical, pharmaceutical, agriculture, and related industries. Our expertise lies in the synthesis of complex organic compounds, including multi-step reactions, chiral compounds, organometallic compounds, asymmetric synthesis, and library molecule synthesis. Our capabilities also extend to impurity synthesis and the synthesis of macrocycles. With a proven track record of delivering compounds from milligram (mg) scale, we have the flexibility to upscale processes to meet the specific requirements of our clients. Driven by a strong focus on precision and excellence, we strive to deliver high-quality solutions that meet the evolving needs of our clients, fostering long-term partnerships and innovation.

Learn More

Our Product

5-Amino-4-methyl-1-phenyl-1,2-dihydro-pyrazol-3-one CAS = 934397-98-5
2-Methoxy-N-(methoxymethyl)-N-((trimethylsilyl)methyl)ethan-1-amine CAS = 1414566-71-4
1′,4-Dimethyl-1-phenyl[3,4′-bi-1H-pyrazol]-5-amine CAS = 1414571-73-5
4-Phenyl-2-(trifluoromethyl)-5-thiazolamine CAS = 873581-45-4
Explore Products

Mission

 At Synsys Chemicals and Pharmaceuticals LLP, our mission is to become a trusted partner for businesses and organizations seeking innovative chemical and pharmaceutical solutions.

Vision

To become a leading research and manufacturing organization.

Industries We Serve

dinmnhbkxy5vmrdsexqb
feis6lynkgsdzbjuc56f
h1y6tzfefdf48tdfs1wt
hbvtbs6adcpvihzzzprl
jbtxlkveimmccfvevpjd
pdhn8wsbsuy8ahsogtqb
pxztoymvhgex8japtq7t
qx1mwdgukdzxzxc9ymbm
s6ruwj4ltbe8fbtbm1z8
xtktedpf3kya17euvgf8

Core Values

  1. We are committed to delivering “high-quality” services that meet the highest standards of excellence
  2. We encourage “innovation and creativity” in our research approach to staying ahead in the field of pharmaceutical research.
  3. We prioritize “customer satisfaction,” providing exceptional service and support to our clients.
  4. We value “collaboration and partnership” with our clients, working together to achieve common goals and advance our work.

Services

Synsys Chemicals and Pharmaceuticals LLP specializes in a range of services, including

Custom Synthesis

Tailored synthesis solutions to meet specific client needs.

Impurity Synthesis

Synthesis of impurities for analytical and regulatory purposes.

Organometallic Compound Synthesis

Expertise in synthesizing organometallic compounds for various applications.

New Chemical Entity (NCE) Development

Expertise in developing novel compounds for various applications.

Drug Development

Support for drug development.

Library Synthesis

Synthesis of compound libraries for research and development purposes.

Management Team (Founder)

Dr Susmita Nandi (Ph D, Post Doc, MBA (Executive))

Over 25 years of experience
Co-Founder and Director

Dr. Susmita Nandi is a highly accomplished leader and founder member of Synsys Chemicals and Pharmaceuticals LLP. With a strong academic foundation, including a Ph.D. and post-doctoral research experience from esteemed institutions like IIT Kharagpur, the University of Kansas, and NCL Pune, she brings over 25 years of expertise in chemical research and project management. Her executive MBA from MIT, Loni, Maharashtra, further enhances her business acumen. Having worked with renowned organizations such as TCGLife Science, Sai Life Sciences, and Infinia Science, Dr. Nandi leverages her extensive industry knowledge to drive innovation and growth at Synsys. As a director, she plays a pivotal role in shaping the company’s strategic direction, fostering a culture of excellence, and delivering high-quality products that make a meaningful impact.

Dr Debashis Datta (Ph D, DMS)

Over 40 years of R&D, API and techno-commercial experience
Co-Founder and Director

Dr. Debashis Datta brings over 40 years of expertise in R&D, API, and techno-commercial leadership to Synsys Chemicals and Pharmaceuticals LLP. With a distinguished career spanning senior leadership positions at Mylan Global, Merck Development Centre, and Lupin Pharma, Dr. Datta is well-equipped to drive innovation and growth. His vision and strategic direction are instrumental in shaping the company’s future, focusing on developing high-quality products and fostering a culture of excellence. Under Dr. Datta’s guidance, Synsys is poised to make significant strides in the industry.

Dr Snigdha Gupta (Ph D, Post Doc)

Researcher and Academician: Over 15 years of experience
Co-Founder and Director

Dr. Snigdha Gupta brings a wealth of scientific expertise and academic excellence to Synsys Chemicals and Pharmaceuticals LLP. With a Ph.D. in Material Science and postdoctoral research experience from esteemed institutions like IACS, Jadavpur, Kolkatta and The University of Toledo, Ohio, USA, Dr. Gupta is a leading expert in material synthesis and characterization. Her 15+ years of teaching and research experience, including tenure as a Senior Project Scientist and Program Manager at IIT Kharagpur, enables her to drive research excellence, technological innovation, and collaborative development across our R&D initiatives. Dr. Gupta’s leadership and scientific acumen continue to shape Synsys’s vision of delivering cutting-edge chemical and pharmaceutical solutions through a culture of scientific rigor and creativity.

Advisors

Dr Girij Pal Singh

(Ph D, Post Doc, 30 years of R&D, API and techno-commercial experience)
Co-Founder and Director of Athena Generics Pvt Ltd

Dr. Girij Pal Singh, Co-founder and Director of Athene Generics, is a globally recognized expert in Process R&D and Techno-Commercial Strategy. Dr Singh brings over three decades of  leadership experience in process development, technology transfer, and cost optimization. Dr. Singh has an exceptional track record of innovation, having filed over 600 patent applications worldwide, with more than 250 patents granted across the United States, Europe, and India. His pioneering contributions in green chemistry, sustainable synthesis, and process optimization continue to shape the global landscape of industrial chemistry and pharmaceutical manufacturing. In addition to his patent achievements, Dr. Singh is the author of over 60 research publications and has been instrumental in filing more than 200 Drug Master Files (DMFs) for various APIs developed under his leadership at Lupin Limited — further demonstrating his ability to translate innovative science into globally recognized industrial success. As an advisor, Dr. Singh’s vast experience and industry insights will enable us to drive excellence, optimize processes, and deliver high-quality products that meet global standards. 

Dr. Purna Chandra Ray

(Ph.D. and M.Phil. in Chemistry, over 35 years of experience)
Co-Founder and Director of GPC Life Sciences Pvt. Ltd

The inclusion of Dr. Purna Chandra Ray in the advisory board of Synsys Chemicals and Pharmaceuticals LLP is a strategic move that brings significant value to the company. As a seasoned synthetic organic chemist with a Ph.D. and M.Phil. in Chemistry from the University of Delhi, Dr. Ray brings over 35 years of experience in pharmaceutical R&D, having worked with top Indian pharmaceutical companies like Ranbaxy, Mylan, Lupin, GVK, and Arene. His expertise in generic drug development, patent invalidation strategies, and regulatory affairs will provide Synsys with valuable insights and guidance. With several international journal publications and patents in the US and Europe, Dr. Ray’s contributions are expected to drive innovation, enhance product development, and ensure compliance with regulatory requirements. His role in shaping Synsys’ strategic direction will likely focus on leveraging his extensive knowledge to foster growth, improve decision-making, and expand the company’s presence in the pharmaceutical and chemical industries

Get in Touch

Please enable JavaScript in your browser to complete this form.
Scroll to Top